Read the full paper: Curious to hear your perspective: how should we think about endpoints in a rapidly evolving oncology landscape
However, one study found that headaches occurred slightly more often in people taking tirzepatide than the placebo: 9.4% of people taking Zepbound or Mounjaro reported headache, compared to 7.5% taking a placebo
Less invasive procedures are on the rise, and were learning more about the genetic causes of epilepsyespecially in children
Male-Female Differences & Conflict (01:40:36) Genes, Boys vs Girls, Impulse Control (01:45:00) Behavior Punishment vs Rewards, Responsibility (01:51:29) Sponsor: Helix Sleep (01:53:03) Accountability
But it is the exact benefit the researchers expected to find, and did in fact validate, in the current study
UV rays trigger melanin production (darkening), which works against what glutathione is trying to do